Page 152 - 南京医科大学自然版
P. 152

第45卷第8期
               ·1208 ·                           南 京    医 科 大 学 学         报                        2025年8月


             [9] CHEN D,LIN X,ZHANG C,et al. Activated Wnt signal⁃   1601-1607
                   ing promotes growth and progression of AFP ⁃ producing  [21]王晓辉,张  威,郭玉霖,等. 甲胎蛋白升高型胃癌的临
                   gastric cancer in preclinical models[J]. Cancer Manag  床病理特征及预后分析[J]. 中国医刊,2023,58(1):
                   Res,2019,11:1349-1362                             63-66
             [10]HU X,CHEN R,WEI Q,et al. The landscape of alpha fe⁃  WANG X H,ZHANG W,GUO Y L,et al. Clinicopatholog⁃
                   toprotein in hepatocellular carcinoma:where are we?[J].  ical features and prognostic analysis of alpha⁃fetoprotein⁃
                   Int J Biol Sci,2022,18(2):536-551                 producing gastric cancer[J]. Chinese Journal of Medi⁃
             [11]FUJIMOTO M,MATSUZAKI I,NISHINO M,et al. HER2        cine,2023,58(1):63-66
                   is frequently overexpressed in hepatoid adenocarcinoma  [22]MAO X,WANG J,LUO F. Alpha⁃fetoprotein can promote
                   and gastric carcinoma with enteroblastic differentiation:a  gastric cancer progression via upregulation of metastasis⁃
                   comparison of 35 cases to 334 gastric carcinomas of other  associated colon cancer 1[J]. Oncol Lett,2022,23(3):
                   histological types[J]. J Clin Pathol,2018,71(7):600-  84
                   607                                          [23]ZHAN Z,CHEN B,YU J,et al. Elevated serum alpha⁃fe⁃
             [12]LU J,DING Y,CHEN Y,et al. Whole⁃exome sequencing    toprotein is a significant prognostic factor for patients
                   of alpha⁃fetoprotein producing gastric carcinoma reveals  with gastric cancer:results based on a large⁃scale retro⁃
                   genomic profile and therapeutic targets[J]. Nat Commun,  spective study[J]. Front Oncol,2022,12:901061
                   2021,12:3946                                 [24]WANG R,LI J,XU D,et al. Dynamic change in serum al⁃
             [13]KAMEI S,KONO K,AMEMIYA H,et al. Evaluation of       pha ⁃ fetoprotein level predicts treatment response and
                   VEGF and VEGF⁃C expression in gastric cancer cells pro⁃  prognosis of alpha⁃fetoprotein⁃producing gastric cancer
                   ducing α⁃fetoprotein[J]. J Gastroenterol,2003,38(6):  [J]. Medicine,2020,99(47):e23326
                   540-547                                      [25]TAKAYAMA⁃ISAGAWA Y,KANETAKA K,KOBAYAS⁃
             [14]KONG X X,LI X L,TIAN Y,et al. The clinicopathologi⁃  HI S,et al. High serum alpha⁃fetoprotein and positive im⁃
                   cal characteristics of alpha⁃fetoprotein⁃producing adeno⁃  munohistochemistry of alpha ⁃ fetoprotein are related to
                   carcinoma of the gastrointestinal tract⁃a single⁃center ret⁃  poor prognosis of gastric cancer with liver metastasis[J].
                   rospective study[J]. Front Oncol,2021,11:635537   Sci Rep,2024,14(1):3695
             [15]WENG W,ZHANG M,NI S,et al. Decreased expression  [26]VATANSEVER S,ÖZER M K,ERDOGAN E I. Prognostic
                   of claudin ⁃ 18.2 in alpha ⁃ fetoprotein ⁃ producing gastric  significance of α⁃fetoprotein in gastric adenocarcinoma[J].
                   cancer compared to conventional gastric cancer[J]. J Gas⁃  Prz Gastroenterol,2022,17(1):35-40
                   trointest Oncol,2022,13(3):1035-1045         [27]ZHANG F. Recurrent metastatic patterns and prognosis af⁃
             [16]WANG Y K,SHEN L,JIAO X,et al. Predictive and prog⁃  ter radical surgery in patients with alpha⁃fetoprotein⁃pro⁃
                   nostic value of serum AFP level and its dynamic changes  ducing gastric cancer:a retrospective cohort study[J].
                   in advanced gastric cancer patients with elevated serum  Am J Cancer Res,2024,14(5):2124-2140
                   AFP[J]. World J Gastroenterol,2018,24(2):266-273  [28]TONG Y,ZHAO Y,SHAN Z,et al. CA724 predicts over⁃
             [17]HE R,YANG Q,DONG X,et al. Clinicopathologic and     all survival in locally advanced gastric cancer patients
                   prognostic characteristics of alpha⁃fetoprotein⁃producing  with neoadjuvant chemotherapy[J]. BMC Cancer,2021,
                   gastric cancer[J]. Oncotarget,2017,8(14):23817-   21:4
                   23830                                        [29]JIN C,HU J,BALAPATTABI K,et al. Case report:a rare
             [18]BOZKAYA Y,DEMIRCI N S,KURTIPEK A,et al. Clini⁃      occurrence of triple malignancy of the stomach,rectum
                   copathological and prognostic characteristics in patients  and liver in a single patient[J]. Front Oncol,2022,12:
                   with AFP⁃secreting gastric carcinoma[J]. Mol Clin On⁃  945689
                   col,2017,7(2):267-274                        [30]ABE D,AKAZAWA Y,YATAGAI N,et al. Clinicopatho⁃
             [19]OTA T,SAKASHITA K,SAWADA R,et al. Long⁃term         logical characteristics of gastric adenocarcinoma with en⁃
                   survival with nivolumab followed by irinotecan after total  teroblastic differentiation and gastric adenocarcinoma
                   gastrectomy in alpha ⁃ fetoprotein ⁃ producing gastric can⁃  with enteroblastic marker expression[J]. Virchows Ar⁃
                   cer:a case report and review of the literature[J]. Surg  chiv,2023,483(3):405-414
                   Case Rep,2023,9(1):71                        [31]LLI M,MEI Y X,WEN J H,et al. Hepatoid adenocarcino⁃
             [20]HORI S,HONDA M,KOBAYASHI H,et al. A grading         ma⁃clinicopathological features and molecular characteris⁃
                   system for predicting the prognosis of gastric cancer with  tics[J]. Cancer Lett,2023,559:216104
                   liver metastasis[J]. Jpn J Clin Oncol,2021,51(11):  [32]USHIKU T,SHINOZAKI A,SHIBAHARA J,et al. SALL4
   147   148   149   150   151   152   153   154   155   156   157